XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating activities    
Net income $ 155,982 $ 237,607
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 100,568 95,764
Equity in net income of unconsolidated affiliates (14,547) (17,165)
Deferred income taxes 2,083 36,926
Stock-based compensation 16,375 37,792
Gain on FFF Put and Call Rights 0 (64,110)
Other, net 3,066 4,578
Changes in operating assets and liabilities, net of the effects of acquisitions:    
Accounts receivable, inventories, prepaid expenses and other assets 47,389 91,418
Contract assets (31,975) (39,139)
Accounts payable, accrued expenses, deferred revenue, revenue share obligations and other liabilities 52,237 (48,882)
Net cash provided by operating activities 331,178 334,789
Investing activities    
Purchases of property and equipment (58,464) (61,061)
Acquisition of businesses and equity method investments, net of cash acquired (187,750) (26,000)
Investment in unconsolidated affiliates (2,060) (16,000)
Other (1,510) (10,000)
Net cash used in investing activities (249,784) (113,061)
Financing activities    
Payments made on notes payable (76,024) (75,082)
Proceeds from credit facility 350,000 300,000
Payments on credit facility (265,000) (125,000)
Proceeds from exercise of stock options under equity incentive plan 704 37,385
Cash dividends paid (75,227) (72,861)
Repurchase of Class A common stock (held as treasury stock) 0 (250,129)
Other, net (10,489) 14,318
Net cash used in financing activities (76,036) (171,369)
Effect of exchange rate changes on cash flows (8) 3
Net increase in cash and cash equivalents 5,350 50,362
Cash and cash equivalents at beginning of period 86,143 129,141
Cash and cash equivalents at end of period $ 91,493 $ 179,503